FIELD: medicine.
SUBSTANCE: present invention relates to methods for treating and/or preventing mucositis using the compound of Formula III or pharmaceutically acceptable salts thereof and to the pharmaceutical composition comprising the compound of Formula III and palifermin.
EFFECT: methods for treating and/or preventing mucositis using the compound of Formula III are disclosed.
11 cl, 5 tbl, 5 ex
III
| Title | Year | Author | Number |
|---|---|---|---|
| ENZYMATIC CLEAVAGE OF SELECTIVE MODULATORS OF ESTROGEN RECEPTORS | 2001 |
|
RU2213778C2 |
| PROTEIN KINASE INHIBITOR (VERSIONS), USE THEREOF FOR TREATING ONCOLOGICAL DISEASES AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477723C2 |
| SOMATOSTATIN RECEPTOR ANTAGONISTS AND METHODS FOR USING THEM | 2017 |
|
RU2740464C2 |
| SYNTHETIC METHOD OF REDUCING ALKYLATING OF INDOLES IN C-3-POSITION | 2004 |
|
RU2352560C2 |
| CONJUGATES OF BINDER (ADC) WITH KSP INHIBITORS | 2014 |
|
RU2698697C2 |
| NEW BICYCLIC PYRAZOLE DERIVATIVES | 2018 |
|
RU2781426C2 |
| USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
| COMPOUNDS USED FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | 2016 |
|
RU2745065C2 |
| KINASES MODULATION AND INDICATIONS FOR ITS USE | 2012 |
|
RU2631487C2 |
| MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
